the 5th International Workshop on Rotavirus and norovirus in china
Epidemiology, Virology and Vaccines
Shanghai, May 8-9, 2024
Meeting Agenda
Day One (Rotavirus)
07:40-08:00 | Registration | |
Opening Session Moderators: Dr. Bao-Ming Jiang | ||
08:00-08:08 | Welcome note and introduction | Dr. Fan Wu Shanghai Medical College, Fudan University |
08:08-08:16 | Opening remarks | Dr. Zi-Jian Feng (virtually) Chinese Preventive Medicine Association |
08:16-08:24 | Opening remarks | Dr. Ji-Zong Li Shanghai Center for Biomedicine Development |
08:24-08:30 | Opening remarks | Dr. Roger Glass Chinese Medical Board |
08:30-09:00 | Keynote: Global rotavirus vaccine introduction and impact | Dr. Jackie Tate Center for Diseases Control and Prevention, USA |
09:00-09:30 | Keynote: Development Pipeline of Vaccines Targeting Diarrheal Pathogens | Dr. Carl Kirkwood Bill & Melinda Gates Foundation |
09:30-09:45 Coffee Break | ||
Session One: Immunization of Rotavirus Vaccine: Impact and Experience Moderators: Dr. Zheng-Lun Liang | ||
09:45-10:10 | Epidemiological Characteristics of Rotavirus Diarrhea in China，2014-2024 | Dr. Jing-Xin Li Center for Diseases Control and Prevention, China |
10:10-10:35 | The Immunization of Rotavirus Vaccine in Vietnam | Dr. Duong Thi Hong National Institute for Hygiene and Epidemiology |
10:35-11:00 | Etiology of Hospitalized Diarrhea in Children in Low- and Middle-Income Countries: Results from the Global Pediatric Diarrhea Surveillance Network, 2017-2022 | Dr. Jie Liu School of Public Health, Qingdao University |
11:00-11:25 | Transmission Dynamics Modeling in Chinese Infants | Ms. Si-Jie Wang Shanghai Institute of Infectious Disease and Biosecurity, Fudan University |
11:25-11:50 | Impact and Cost-Effectiveness of Rotavirus Vaccination in LIMICs | Dr. Fred Debellut PATH |
11:50-12:15 | Cost-Effectiveness Analysis of Rotavirus Vaccination in China | Dr. Shen-Yu Wang Center for Diseases Control and Prevention, Zhejiang |
12:15-13:30 Lunch | ||
Session Two: Development of RV Vaccines Moderators: Dr. You-Chun Wang | ||
13:30-13:55 | RV3-BB Rotavirus Vaccine: a Human Neonatal Rotavirus Vaccine to Target Rotavirus Disease with Birth Dose or Infant Administration Schedule | Dr. Julie Bines (virtually) Department of Paediatrics, University of Melbourne |
13:55-14:15 | Development and Clinical Study of Reassortant Trivalent Rotavirus (RV) Vaccine | Dr. Yun-Jin Wang Lanzhou Institute of Biological Products Co., Ltd. |
14:15-14:35 | Development of Hexavalent Rotavirus Vaccine (RV6) | Dr. Ge-Lin Xu Wuhan Institute of Biological Products Co., Ltd. |
14:35-15:05 | Keynote: World Health Organization-Coordinated Surveillance of Pediatric Diarrheal Diseases in Low- and Middle-Income Countries | Dr. Heidi Soeters (virtually) World Health Organization |
15:05-15:20 Coffee Break | ||
Session Three: Development of Next Generation Rotavirus Vaccines Moderators: Dr. Yuan Qian | ||
15:20-15:45 | Development of parenteral Rotavirus Vaccines: Rationale, Design and Correlates of Protection | Dr. Baoming Jiang Center for Diseases Control and Prevention, USA |
15:45-16:10 | The Intestinal Microbiome and Rotavirus Vaccine Performance, Bilateral Impacts for | Dr. Vanessa Harris Institute for Global Health and Development University of Amsterdam |
16:10-16:40 | Progress Towards Clinical Development of Inactivated RV Vaccine | Dr. Li-Jie Zhang Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd. |
16:40-17:05 | A VP4-Based Trivalent Pseudovirus Nanoparticle Vaccine against Rotaviruses | Dr. Ming Tan Cincinnati Children’s Hospital Medical Center, College of Medicine, University of Cincinnati |
17:05-17:30 | Progress Towards the Development of VP4-Based Rotavirus Vaccines | Dr. Ting-Dong Li School of Public Health, Xiamen University |
17:30 | Dinner | |
Day One Night (Road Map for Introduction of Rotavirus Vaccine into NIP)
Invited Only
Moderators: Dr. Hua-Qing Wang and Dr. Roger Glass | ||
19:00-19:20 | Overview of Global Rotavirus Immunization | Dr. Roger Glass China Medical Board |
19:20-19:40 | The Current Status of Rotavirus Vaccination, the Prospect and Process of Integrating into Chinese NIP | Dr. Fu-Zhen Wang Center for Diseases Control and Prevention, China |
19:40-20:00 | Considerations on the Introduction of Varicella Vaccine to the Childhood Immunization Program in Shanghai | Dr. Xiao-Dong Sun Center for Diseases Control and Prevention, Shanghai |
20:00-20:50 | Group Discussion | |
20:50-21:00 | Recap | Dr. Zi-Jian Feng (virtually) Chinese Preventive Medicine Association |
Day Two (Norovirus)
Session One: Epidemiology and Diseases Burden Moderators: Dr. Zhao-Jun Duan | ||
08:30-09:00 | Keynote: Epidemiology and Burden of Norovirus Disease | Dr. Umesh Parashar Center for Diseases Control and Prevention, USA |
09:00-09:25 | Transmission of Norovirus among Infants in Rural China: a Birth Cohort Study | Dr. Xuan-Yi Wang Shanghai Institute of Infectious Disease and Biosecurity, Fudan University |
09:25-09:50 | Molecular Epidemiology and Evolution of Norovirus in China | Dr. Jin Miao Center for Diseases Control and Prevention, China |
09:50-10:15 | Progress Toward Study of Norovirus | Dr. Trang Nguyen National Institute for Hygiene and Epidemiology, Vietnam |
10:15-10:35 Coffee Break | ||
Session One: Epidemiology and Diseases Burden (Cont.) Moderators: Dr. Tony Nelson | ||
10:35-11:00 | Burden of Rotavirus and Norovirus in the Philippines | Dr. Michelle Ylade University of the Philippines Manila |
11:00-11:15 | Rotavirus & Norovirus in Malaysia: Prevalence and Challenges | Dr. Jeffrey Lee Clinical Research Centre, Sibu Hospital, Ministry of Health Malaysia |
11:15-11:40 | Norovirus Surveillance in Beijing, China | Dr. Zhi-Yong Gao Center for Disease Control and Prevention, Beijing |
11:40-12:05 | Surveillance of Norovirus and Rotavirus in Population and in Sewage in Pudong, Shanghai | Dr. Li-Feng Pan Center for Disease Control and Prevention, Pudong, Shanghai |
12:05-13:30 Lunch | ||
Session Two: Development of Norovirus Vaccines Moderators: Dr. Xi Jason Jiang | ||
13:30-13:55 | Clinical Experiences from the Development of a Norovirus VLP Vaccine | Dr. David Swerdlow HilleVax, Inc. |
13:55-14:20 | Harnessing Germline Immune Memory as New mucosal Adjuvanticity Strategy for Enteric Infections | Dr. Diana Boraschi ShenZhen Institute of Advanced Technology, Chinese Academy Sciences |
14:20-14:45 | Gnotobiotic Pig Models for the Study of Human Norovirus and Vaccine Preclinical Evaluation | Dr. Lijuan Yuan Department of Biomedical Sciences and Pathobiology Virginia Tech |
14:45-15:00 Coffee Break | ||
15:00-15:25 | Human Norovirus Evolution, Cross-Reactive Immunity, and Vaccine Design | Dr. Ji-Guo Su China National Pharmaceutical Group Co Ltd. |
15:25-15:55 | Clinical Investigation of Quadrivalent Human Recombinant Noroviruses Vaccine (Pichia Pastoris) | Dr. En-Qi Huang Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. |
15:55-16:05 | Closing remark | Dr. Baoming Jiang Center for Disease Control and Prevention, USA |
16:05-16:15 | Closing remark | Dr. Fujie Xu Bill & Melinda Gates Foundation, China office |
Dr. Yu Kong
Email: Kongyu@Fudan.Edu.Cn
Mobile: 15801735741
